Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Phases of Wound Repair

Phases of Wound Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Healing II: Complications

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Revista espanola de cirugia ortopedica y traumatologia·2026

Same author

A new dynamic technique for healing aseptic subtrochanteric hip nonunion: Detailed technique and review of literature.

Revista espanola de cirugia ortopedica y traumatologia·2026

Same author

The role of six biomarkers in diagnosis of hemophilic arthropathy: review of the literature.

Journal of biological regulators and homeostatic agents·2020

Same author

Tranexamic acid is effective in decreasing postoperative intraarticular bleeding in arthroscopic knee surgery.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2020

Same author

Topical therapies for knee osteoarthritis.

Postgraduate medicine·2018

Same author

Recommendations on multidisciplinary management of elective surgery in people with haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Search research articles

Related Experiment Video

Updated: May 24, 2026

Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis

Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis

Published on: August 21, 2020

Surgical wound healing in bleeding disorders.

E C Rodriguez-Merchan¹

¹Department of Orthopaedic Surgery, La Paz University Hospital and School of Medicine, Autonomous University, Madrid, Spain. ecrmerchan@gmx.es

Haemophilia : the Official Journal of the World Federation of Hemophilia

|February 17, 2012

Summary

Adequate hemostasis is crucial for surgical wound healing in patients with bleeding disorders. Maintaining sufficient hemostasis for 2-3 weeks post-surgery may prevent complications like hematomas and infection.

More Related Videos

Protocol to Create Chronic Wounds in Diabetic Mice

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis

Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis

Published on: August 21, 2020

Protocol to Create Chronic Wounds in Diabetic Mice

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Area of Science:

Medical Science
Surgical Innovation
Hematology

Background:

Bleeding disorders such as hemophilia B, factor XIII deficiency, and fibrinogen abnormalities can impair wound healing (WH).
Normal wound healing necessitates adequate hemostatic function for up to 4 weeks in clean, uncontaminated wounds.
Numerous factors, including diabetes, poor nutrition, infection, and obesity, can negatively impact WH.

Purpose of the Study:

To explore the necessity of adequate hemostasis for surgical wound healing in patients with bleeding disorders.
To identify potential complications arising from insufficient hemostasis during the healing process.
To propose an optimal duration for maintaining hemostasis to ensure satisfactory surgical wound healing.

Main Methods:

Review of animal experiments and clinical observations regarding wound healing in bleeding disorder patients.
Analysis of factors affecting wound healing.
Evaluation of current gold standard care for surgical wounds in this patient population.

Main Results:

Impaired hemostasis, even at low levels or for insufficient durations, can lead to WH complications like hematomas, infection, skin necrosis, and dehiscence.
Animal studies and clinical experience suggest that maintaining good hemostasis for 2-3 weeks post-surgery is necessary for satisfactory healing and complication avoidance.
Current standards of care may not align with this extended hemostasis recommendation.

Conclusions:

Maintaining adequate hemostasis for 2-3 weeks is indicated for optimal surgical wound healing in patients with bleeding disorders.
While complications are uncommon, insufficient hemostasis poses risks, necessitating careful management.
Further clinical evidence is required to fully support the proposed extended hemostasis duration.